Kaneka has unveiled KANEKA KanCapA, a new protein A chromatography resin to purify therapeutic antibodies. Protein A chromatography resin is widely used to produce antibodies due to its high affinity and excellent selectivity for ...
One Lambda (OLI ) has signed a supply agreement with CellTrend, which allows OLI to market and distribute the Immuno-Assay product, EIA. EIA is used for Quantitative Determination of anti-Angiotensin II Receptor 1 (AT1) Antibodies. The ...
Stellar Biotechnologies, a manufacture of Keyhole Limpet Hemocyanin (KLH), has launched Stellar KLH enzyme-linked immunosorbent assay (ELISA) test kits for pharmaceutical immunotoxicology research. The six different kits are designed for ...
Tags: Stellar Biotechnologies, Keyhole Limpet Hemocyanin, KLH, ELISA test kits
pSivida has signed a funded technology evaluation agreement with a biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology in the field of ophthalmology. Tethadur, which uses an injectable, ...
CLC bio has implemented specialized antibody engineering and selection software for Crucell, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, that integrates with CLC bio's bioinformatics platform. The specialized module ...
Tags: CLC bio, bioinformatics platform
ProImmune has introduced B cell ELISpot assay as a service for the characterization of adaptive immune responses to infection, immune modulators, vaccines and therapeutic agents. B cell ELISpot enables the activity of ...
Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone ...
Tags: NG-XMT, clone, monoclonal antibodies
Medistem and Superview Biotechnology, a subsidiary of Yinhuan Holding Co from Yixing, collaborate for the development of therapeutics using antibody and stem cell technology. The collaboration will leverage proprietary stem cell lines ...
Tags: therapeutics, antibody and stem cell technology, regenerative medicine
Janssen Biotech, a Johnson & Johnson company, has executed a license and development agreement for an investigational anti-cancer agent, daratumumab (HuMax-CD38), with Genmab. Daratumumab is a human CD38 monoclonal antibody which is ...
Tags: Daratumumab License, license and development agreement, anti-cancer
The International AIDS Vaccine Initiative (IAVI), GlycoMimetics (GMI), and Glycosensors and Diagnostics (G&D) have collaborated to develop a vaccine against AIDS. The project being funded by IAVI's Innovation Fund will integrate the ...
Tags: HIV vaccine, vaccine against AIDS, carbohydrate immunogens
Pulmatrix has demonstrated iSPERSE capabilities for inhaled dry powder delivery of antibiotics, antibodies and other macromolecules. These preclinical data demonstrated the ability of iSPERSE formulations to deliver stable and ...
Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells. Developed in collaboration with pharma and biotechnology companies, the Cellaxess platform enables scalable ...
Tags: Cellectricon, Cellaxess elektra discovery platform, adherent cells
AbD Serotec, MorphoSys' division for research and diagnostic antibodies, is set to introduce a series of the human combinatorial antibody library (HuCAL) anti-drug antibodies supporting the development of novel antibody therapeutics. The ...
Tags: AbD Serotec, HuCAL Anti-Drug Antibodies, antibody therapeutics, MorphoSys
Antibody-drug conjugate (ADC) company, Mersana Therapeutics and Adimab have initiated a joint effort to offer integrated antibody discovery and ADC technologies. The partnership will provide pharmaceutical companies an access to Adimab's ...
Tags: Adimab, Mersana, integrated antibody discovery, ADC technologies
AET BioTech and BioXpress Therapeutics have signed a research deal for the development of a biosimilar version of the TNF inhibitor MAb Adalimumab. Under the agreement, both the companies will be responsible for the development, ...
Tags: AET BioTech, BioXpress Therapeutics, TNF Inhibitor, research deal